# Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery

> **NCT00905450** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 415 (actual)

## Conditions studied

- Cataract
- Inflammation

## Interventions

- **DRUG:** BOL-303242-X
- **DRUG:** Vehicle for BOL-303242-X

## Key facts

- **NCT ID:** NCT00905450
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-05
- **Target enrollment:** 415 (ACTUAL)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905450, "Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00905450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*